Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Robert

Showing results (51-60 of 512) with videos related to

Pageof 52
Sort By:
Oncology|November 20, 2009
Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinibAdam D Lipworth, Caroline Robert, Andrew X Zhu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patientsPatrick A Ott, F Stephen Hodi, Caroline Robert
Lancet (London, England)|September 24, 2013
Cutaneous melanomaAlexander M M Eggermont, Alan Spatz, Caroline Robert
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Systemic Therapy Options for Patients With Unresectable MelanomaMelinda Yushak, Paul Chapman, Caroline Robert, et al.
Nature Reviews. Cancer|August 3, 2021
The plasticity of mRNA translation during cancer progression and therapy resistanceLucilla Fabbri, Alina Chakraborty, Caroline Robert, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2021
Abscopal antitumor effect in a patient with melanoma and coronavirus disease 2019Hugo Herrscher, Benoit Sauer, Pierre Truntzer, et al.
Bulletin Du Cancer|January 30, 2023
[Use of genome-wide testing in oncology: French expert opinion based on the Delphi methodology]Olivier Trédan, Caroline Robert, Antoine Italiano, et al.
Seminars in Oncology|April 10, 2012
Advances in the management of cutaneous toxicities of targeted therapiesCaroline Robert, Vincent Sibaud, Christine Mateus, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2013
Drug of the year: programmed death-1 receptor/programmed death-1 ligand-1 receptor monoclonal antibodiesCaroline Robert, Jean-Charles Soria, Alexander M M Eggermont
Oncoimmunology|April 11, 2014
Harnessing the immune system to provide long-term survival in patients with melanoma and other solid tumorsAlexander Eggermont, Caroline Robert, Jean Charles Soria, et al.
Pageof 52

Showing results (51-60 of 512) with videos related to

Sort By:
Pageof 52
Oncology|November 20, 2009
Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinibAdam D Lipworth, Caroline Robert, Andrew X Zhu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patientsPatrick A Ott, F Stephen Hodi, Caroline Robert
Lancet (London, England)|September 24, 2013
Cutaneous melanomaAlexander M M Eggermont, Alan Spatz, Caroline Robert
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Systemic Therapy Options for Patients With Unresectable MelanomaMelinda Yushak, Paul Chapman, Caroline Robert, et al.
Nature Reviews. Cancer|August 3, 2021
The plasticity of mRNA translation during cancer progression and therapy resistanceLucilla Fabbri, Alina Chakraborty, Caroline Robert, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2021
Abscopal antitumor effect in a patient with melanoma and coronavirus disease 2019Hugo Herrscher, Benoit Sauer, Pierre Truntzer, et al.
Bulletin Du Cancer|January 30, 2023
[Use of genome-wide testing in oncology: French expert opinion based on the Delphi methodology]Olivier Trédan, Caroline Robert, Antoine Italiano, et al.
Seminars in Oncology|April 10, 2012
Advances in the management of cutaneous toxicities of targeted therapiesCaroline Robert, Vincent Sibaud, Christine Mateus, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2013
Drug of the year: programmed death-1 receptor/programmed death-1 ligand-1 receptor monoclonal antibodiesCaroline Robert, Jean-Charles Soria, Alexander M M Eggermont
Oncoimmunology|April 11, 2014
Harnessing the immune system to provide long-term survival in patients with melanoma and other solid tumorsAlexander Eggermont, Caroline Robert, Jean Charles Soria, et al.
Pageof 52